Literature DB >> 18591021

Lack of toxicity of human neuromelanin to rat brain dopaminergic neurons.

Y Aimi1, P L McGeer.   

Abstract

Neuromelanin extracts from the substantia nigra of a parkinsonian and a non-parkinsonian case were injected into the substantia nigra and caudate-putamen of rat brains. Rats were sacrificed at periods ranging from 3 days to 8 months. Substantial amounts of neuromelanin remained at both injection sites even after 8 months, indicating a very slow rate of phagocytosis. No differences were seen in the reaction to control or parkinsonian melanin, and no neurotoxicity attributable to the melanin was observed. These data fail to support the hypothesis of neurotoxicity of melanin as a cause of Parkinson's disease.

Entities:  

Year:  1996        PMID: 18591021     DOI: 10.1016/1353-8020(96)00004-1

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  6 in total

Review 1.  Functional effects of neuromelanin and synthetic melanin in model systems.

Authors:  K L Double
Journal:  J Neural Transm (Vienna)       Date:  2006-05-05       Impact factor: 3.575

Review 2.  α-Synuclein in Parkinson's disease: causal or bystander?

Authors:  Peter Riederer; Daniela Berg; Nicolas Casadei; Fubo Cheng; Joseph Classen; Christian Dresel; Wolfgang Jost; Rejko Krüger; Thomas Müller; Heinz Reichmann; Olaf Rieß; Alexander Storch; Sabrina Strobel; Thilo van Eimeren; Hans-Ullrich Völker; Jürgen Winkler; Konstanze F Winklhofer; Ullrich Wüllner; Friederike Zunke; Camelia-Maria Monoranu
Journal:  J Neural Transm (Vienna)       Date:  2019-06-25       Impact factor: 3.575

3.  Neuromelanin Modulates Heterocyclic Aromatic Amine-Induced Dopaminergic Neurotoxicity.

Authors:  Vivek Lawana; Se Young Um; Jean-Christophe Rochet; Robert J Turesky; Jonathan H Shannahan; Jason R Cannon
Journal:  Toxicol Sci       Date:  2020-01-01       Impact factor: 4.849

Review 4.  The role of anti-inflammatory agents in Parkinson's disease.

Authors:  Edith G McGeer; Patrick L McGeer
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

5.  Neuromelanin formation exacerbates HAA-induced mitochondrial toxicity and mitophagy impairments.

Authors:  Vivek Lawana; Se Young Um; Rachel M Foguth; Jason R Cannon
Journal:  Neurotoxicology       Date:  2020-10-13       Impact factor: 4.294

Review 6.  Neuromelanin and its interaction with iron as a potential risk factor for dopaminergic neurodegeneration underlying Parkinson's disease.

Authors:  Manfred Gerlach; Kay L Double; Dorit Ben-Shachar; Luigi Zecca; Moussa B H Youdim; Peter Riederer
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.978

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.